Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Sci Rep ; 13(1): 21432, 2023 Dec 05.
Article in English | MEDLINE | ID: mdl-38052839

ABSTRACT

In this paper, we consider new quantum mechanisms for selective detection in complex gaseous media which provide the highest possible efficiency of quantum sensors and for the first time analyze their nature. On the basis of these quantum mechanisms, the concepts of quantum detection and innovative methods of analysis are developed, which are virtually impossible to implement in the conventional conductive sensors and nanosensors. Examples of original solutions to problems in the field of detection and analysis of human breath using point-contact sensors are considered. A new method of analysis based on detection of metastable quantum states of the "point-contact sensor-breath" system in dynamic mode is proposed. The conductance histogram of dendritic Yanson point contacts recorded for this system is a unique energy signature of breath which allows differentiation between the states of human body. We demonstrate that nanosized Yanson point contacts, which, thanks to their quantum properties, can replace a massive spectrometer, open up wide opportunities for solving complex problems in the field of breath analysis using a new generation of portable high-tech quantum sensor devices.

2.
Bratisl Lek Listy ; 123(1): 3-8, 2022.
Article in English | MEDLINE | ID: mdl-34967651

ABSTRACT

OBJECTIVES: Evaluation of the impact of surgical treatment on malignant transformation (MT) of adult supratentorial infiltrative grade II gliomas (G2G) in a series of chemotherapy and radiotherapy-naïve patients. BACKGROUND: Despite G2G are slow-growing tumours, they typically undergo MT with a subsequent fatal disease course. An extensive resection alone likely changes their biological behaviour and defers MT; however, this impact is not unequivocally confirmed. METHODS: Thirty-eight chemotherapy and radiotherapy-naïve adult patients operated from 2005 till 2014 for a G2G were investigated. Based on postoperative magnetic resonance imaging (MRI) and/or positron emission tomography follow-up (FU) scans, the patients were classified as "transformers" (15 patients in whom MT occurred during the FU-period) and "non-transformers" (23 patients). RESULTS: The follow-up period of "non-transformers" was longer (p <0.0001). After adjustment for known risk factors - age, male sex, astrocytoma histology, preoperative tumour volume, preoperative contrast enhancement and positive isocitrate dehydrogenase 1 gene mutation status - a larger log postoperative tumour volume (p=0.031) and a smaller extent of resection (p=0.0086) were associated with a shorter MT-free survival. CONCLUSION: In our series, less extensive resections were associated with a shorter time to MT. Our data support an adoption of techniques enabling extensive G2G resections, such as intraoperative imaging and awake resections, into everyday routine (Tab. 1, Fig. 2, Ref. 40).


Subject(s)
Brain Neoplasms , Glioma , Adult , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Disease Progression , Glioma/diagnostic imaging , Glioma/surgery , Humans , Magnetic Resonance Imaging , Male , Neoplasm, Residual , Tumor Burden
3.
Bratisl Lek Listy ; 120(9): 663-667, 2019.
Article in English | MEDLINE | ID: mdl-31475550

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the indication of neoadjuvant therapy in patients with middle and low rectal cancer based on MRI examination. BACKGROUND: In spite of noticeable advances in the diagnosis of rectal cancer, the optimal treatment remains highly debated. Current guidelines advise the use of neoadjuvant therapy in UICC stage II patients or higher. However, in clinical praxis, there is gradual implementation of new criterions and variables used in rectal cancer stage evaluation, the fact of which influences the treatment choice. The most important emerging variables taken currently into account are the distance from mesorectal fascia, circumferential resection margin, extramural venous invasion and intersphincteric plane, all of which can be evaluated using the MRI examination. METHODS: The accuracy of MRI staging was compared with definite histopathological results from resected tumors. Patient data were prospectively collected between the years 2013 and 2018 at 3rd Surgical Clinic, Faculty of Medicine, Comenius University in Bratislava, Slovakia. Data from 101 patients were gathered and divided into two groups, according to the localization of tumor within rectum, while 9 patients were excluded from the study because of benign lesion diagnosis based upon final histopathologic evaluation. RESULTS: In 92 evaluated patients, no significant change was noted between MRI and histopathological T-staging. However, in N-staging, significant differences were noted between preoperative MRI staging and postoperative histopathological staging. CONCLUSION: The results of this study demonstrate inefficient preoperative lymph node staging, suggesting overtreatment of rectal cancer patients. Although the use of neoadjuvant therapy has led to great advances in modern cancer treatment, it is connected with a number of side effects and therefore should be indicated only for patients who can benefit from this treatment (Tab. 1, Fig. 3, Ref. 16).


Subject(s)
Magnetic Resonance Imaging , Neoadjuvant Therapy , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/drug therapy , Humans , Neoplasm Staging , Slovakia
4.
Neoplasma ; 66(3): 494-498, 2019 05 23.
Article in English | MEDLINE | ID: mdl-30793609

ABSTRACT

In past decades, both prognosis and therapy of rectal cancer patients showed significant improvement, on the other hand, the incidence of rectal carcinoma continues to have a rising tendency. According to current UICC classification, patients in stage II rectal cancer or higher are indicated for neoadjuvant chemoradiotherapy (nCRT). Magnetic resonance imaging (MRI) is currently the most common diagnostic method used for preoperative staging of rectal cancer. Several studies already pointed out the inaccuracy of preoperative lymph node staging in patients with rectal cancer. The present study analyzed overall accuracy of MRI staging of rectal cancer and thus its accuracy in neoadjuvant therapy indication, by comparing preoperative MRI staging with definitive histopathologic results from resected tumors. This study evaluated cases of 92 patients with rectal tumor that underwent MRI examination followed by surgical resection. Tumors included in the analysis were ranging from T1 to T3b according to TNM staging, with free circumferential resection margin (CRM), distance form mesorectal fascia more than 5 mm, negative intersphincteric plane and also negative extramural venous invasion (EMVI), while the N stage was not decisive. In all cases both N-staging and T-staging were evaluated histologically and compared with preoperative MRI results. Significant difference in preoperative and postoperative N-staging was shown in 51 patients (61.45%). In majority of cases MRI lead to overstaging, which was observed in 44 cases (53.1 %), with complete negativity of lymph nodes proven by histological examination in 34 cases. On the other hand, understaging of lymph nodes was observed only in 7 cases (7.4 %). The T-staging did not show significant differences. Results from this study confirm that MRI plays an important role in T-staging of rectal tumors, however, there are admittedly issues in N-staging of tumors, which should lead to reevaluation of neoadjuvant therapy indication in patients with positive lymph nodes according to MRI examination. Based on the results of this study, we see the future of preoperative staging of rectal tumors in precise T-staging together with accurate assessment of CRM and distance of tumor from mesorectal fascia as well as evaluation of intersphinteric plane and EMVI.


Subject(s)
Magnetic Resonance Imaging , Neoadjuvant Therapy , Neoplasm Staging , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/therapy , Chemoradiotherapy , Humans
5.
J Hum Hypertens ; 25(6): 391-400, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20631738

ABSTRACT

Impaired insulin action, frequently found in essential hypertension (HT), is modified by other factors, such as higher age, accumulation of body fat, dyslipidaemia, impaired glucose metabolism and endothelial dysfunction. In addition, antihypertensive and insulin-sensitizing medication itself may significantly affect cardiovascular and metabolic milieu. The aim of this study was to assess insulin sensitivity, acute insulin response, lipidaemic status and the adipokines' concentrations with regard to abdominal fat distribution in young, lean male subjects with treatment-naïve essential HT and in matched healthy normotensive (NT) subjects. We studied 27 HT patients (age: 19.9±0.6 years; body mass index (BMI): 22.9±0.5 kg m(-2)) and 15 NT controls (age: 22.3±1.0 years; BMI: 23.7±0.6 kg m(-2)). The subjects underwent an oral and an intravenous glucose tolerance test (OGTT, IVGTT) on separate days in random order. Higher fasting insulin (P<0.001), non-esterified fatty acids (P<0.05) and plasminogen activator inhibitor factor 1 concentrations (P<0.05) were found in HT patients when compared with NT patients. Despite comparable anthropometric parameters and body fat distribution assessed by magnetic resonance imaging in both groups, newly diagnosed untreated young hypertensive male subjects showed decreased insulin sensitivity, augmented insulin response to both oral and intravenous glucose load (P<0.01; P<0.05 respectively) and 'higher still normal' 2-h plasma glucose levels during OGTT. Untreated, young, lean hypertensive male subjects, with distribution of abdominal adipose tissue and lipid profile comparable with their healthy NT matched counterparts, showed considerable signs of insulin resistance and hyperinsulinaemia. We hypothesize that insulin resistance is the initial feature, which is influenced by several environmental factors, and HT is one of their common consequences.


Subject(s)
Hypertension/physiopathology , Insulin Resistance/physiology , Thinness/physiopathology , Adipokines/blood , Body Mass Index , Case-Control Studies , Fatty Acids, Nonesterified/blood , Glucose Tolerance Test , Humans , Hypertension/blood , Insulin/blood , Lipids/blood , Male , Plasminogen Activator Inhibitor 1/blood , Thinness/blood , Young Adult
6.
Bratisl Lek Listy ; 111(1): 41-4, 2010.
Article in English | MEDLINE | ID: mdl-20429311

ABSTRACT

BACKGROUND: Central neurocytoma is a rare primary brain tumour, mostly localised in the lateral ventricles in relation to the foramen of Monro. OBJECTIVES: To report a case of a rare central neurocytoma with a complete loss of Synaptophysin expression and provide the differential diagnosis. METHODS AND RESULTS: We describe a case of a 34-year old man with a headache, unsteady gait and dim vision. MRI demonstrated a tumorous expansion localised in both lateral ventricles. The patient underwent a subtotal resection. Histology showed a picture consistent with central neurocytoma, but tumour was completely negative for Synaptophysin. We describe our approach in such a diagnostically difficult case. CONCLUSIONS: In the rare case of Synaptophysin-negative central neurocytoma, its neuronal differentiation should be substantiated by electron-microscopic examination. Unfortunately in the routine work, biopsy samples are usually fixed in formalin fixative which does not preserve ultrastructure well. In such situations, an accurate diagnosis is disputable and based on careful assessment of the histological features, exclusion of tumours with similar morphology and detailed correlation with MRI pictures (Fig. 4, Ref. 6). Full Text (Free, PDF) www.bmj.sk.


Subject(s)
Cerebral Ventricle Neoplasms/diagnosis , Neurocytoma/diagnosis , Synaptophysin/metabolism , Adult , Cerebral Ventricle Neoplasms/metabolism , Cerebral Ventricle Neoplasms/pathology , Diagnosis, Differential , Humans , Male , Neurocytoma/metabolism , Neurocytoma/pathology
7.
Eur Radiol ; 19(11): 2716-27, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19471942

ABSTRACT

Radiation to the brain and adjuvant chemotherapy may produce late delayed changes from several months to years after treatment of intracranial malignancies with a reported prevalence of 5-24%. The pattern of treatment-related injury may vary from diffuse periventricular white matter lesions to focal or multifocal lesions. Differentiation of treatment-related injury from tumor progression/recurrence may be difficult with conventional MR imaging (MRI). With both disease processes, the characteristic but nonspecific imaging features are vasogenic edema, contrast enhancement, and mass effect. This pictorial essay presents MRI spectra of late therapy-induced injuries in the brain with a particular emphasis on radiation necrosis, the most common and severe form. Novel MRI techniques, such as diffusion-weighted imaging (DWI), proton MR spectroscopy (MRS), and perfusion MRI, improve the possibilities of better characterization of treatment-related changes. Advanced MRI techniques allow for the assessment of metabolism and physiology and may increase specificity for therapy-induced changes.


Subject(s)
Antineoplastic Agents/adverse effects , Brain/drug effects , Brain/pathology , Brain/radiation effects , Drug-Related Side Effects and Adverse Reactions , Magnetic Resonance Imaging/methods , Radiation Injuries/pathology , Adult , Brain Neoplasms/complications , Brain Neoplasms/drug therapy , Brain Neoplasms/radiotherapy , Diagnostic Imaging/methods , Diffusion Magnetic Resonance Imaging , Female , Humans , Magnetic Resonance Spectroscopy/methods , Male , Middle Aged , Necrosis/pathology , Radiation Injuries/diagnosis
8.
Neoplasma ; 56(2): 156-62, 2009.
Article in English | MEDLINE | ID: mdl-19239331

ABSTRACT

UNLABELLED: Presented is the analysis of patients who underwent external beam radiotherapy (EBRT) to the brain in the period from 2003 to 2006 at the department of Radiation Oncology of the St. Elisabeth Cancer Institute.

The aim of our analysis was to identify risk factors of late delayed therapy induced injuries (LDTI) in the brain. The patients were regularly examined with magnetic resonance (MRI), including conventional and advanced techniques: perfusion imaging (pMRI), diffusion weighted imaging (DWI), MRI spectroscopy (MRS). The results from MRI were correlated with 18fluoro-deoxyglucose positron emission tomography (18FDG/PET) scans, as none of the listed method is sufficiently sensitive and specific by itself. Also clinical data records and treatment plans of these patients were analyzed.

In our cohort we found 6 patients with abnormal post-therapeutical changes, 4 of them with MR and 18FDG/PET scans characteristics for LDTI - radiation necrosis. In one patient biopsy was performed and radiation necrosis (RN) was confirmed.

KEYWORDS: radiation necrosis, MRI, PET, 3D conformal radiotherapy (3D-CRT).


Subject(s)
Brain Neoplasms/radiotherapy , Brain/radiation effects , Glioma/radiotherapy , Adult , Brain/pathology , Fluorodeoxyglucose F18 , Humans , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Middle Aged , Positron-Emission Tomography
9.
Gen Physiol Biophys ; 24(3): 327-35, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16308427

ABSTRACT

In vivo magnetic resonance spectroscopy (MRS) studies of glial brain tumours reported that higher grade of astrocytoma is associated with increased level of choline-containing compounds (Cho) and decreased levels of N-acetylaspartate (NAA) and creatine and phosphocreatine (Cr). In this work, we studied the metabolism of glioma tumours by in vitro proton magnetic resonance spectroscopy (1H-MRS). 1H-MR spectra were recorded in vitro from perchloric acid extracts of astrocytoma (WHO II) and glioblastoma multiforme (WHO IV) samples. We observed differences between astrocytoma and glioblastoma multiforme in the levels of Cho, alanine, lactate, NAA, and glutamate/glutamine. In astrocytoma samples, we found higher MR signal of NAA and lower signal of Cho and alanine. MR spectra of glioblastoma samples reported significantly higher levels of lactate and glutamate/glutamine. In contrast, levels of Cr were the same in both tumour types. We also determined NAA/Cr and Cho/Cr ratios in the tumour samples. The NAA/Cr ratio was higher in astrocytomas than in glioblastomas multiforme. Conversely, the Cho/Cr ratio was higher in glioblastoma multiforme. The results indicate that MRS is a promising method for distinguishing pathologies in human brain and for pre-surgical grading of brain tumours.


Subject(s)
Astrocytes/pathology , Astrocytoma/pathology , Brain Neoplasms/pathology , Magnetic Resonance Spectroscopy/methods , Neoplasms/metabolism , Aspartic Acid/analogs & derivatives , Aspartic Acid/therapeutic use , Astrocytoma/metabolism , Brain/metabolism , Brain/pathology , Choline/chemistry , Choline/pharmacology , Chromium/chemistry , Creatine/chemistry , Glioblastoma/chemistry , Glioblastoma/metabolism , Glioma/pathology , Humans , In Vitro Techniques , Phosphocreatine/chemistry , Spectrophotometry
10.
Int Urol Nephrol ; 32(4): 665-7, 2001.
Article in English | MEDLINE | ID: mdl-11989561

ABSTRACT

INTRODUCTION: The therapeutic procedures in the management of testicular cancer are determined by histological findings in the removed testis and by the extent of the disease at the time of diagnosis. However, all advanced tumors could be treated by primary chemotherapy regardless of the histological findings. The current imaging techniques (ultrasound of the testis, abdominal and chest CT examination) and laboratory tests (determination of serum tumor markers AFP and hCG) provide sufficient evidence for the presence of cancer. When the diagnosis of advanced tumor is evident, it is possible to start the treatment without orchiectomy. The aim of this study was to evaluate the advantages of neo-adjuvant chemotherapy with delayed orchiectomy in the management of advanced testicular cancer. MATERIAL AND METHODS: A total of 36 patients with advanced germ cell testicular cancer underwent primary PVB or BEP chemotherapy without previous orchiectomy. Mean age of patients was 32 years. Detailed medical, surgical and urological examination showed pulmonary metastases and/or extensive abdominal tumorous masses imitating acute abdominal crisis and impaired drainage of the kidney due to ureteral obstruction. Searching for the origin, testicular tumor was detected. Eleven patients had a bulky disease in the retroperitoneum (Stage IIC), two had enlarged retroperitoneal lymph nodes (Stage IIB), two had enlarged mediastinal lymph nodes (Stage III) and other 16 patients had also pulmonary metastases, and 5 pts had pulmonary metastases only. The patients were treated with cisplatin-containing combination chemotherapy. Following completion of chemotherapy, orchiectomy was performed alone or simultaneously with retroperitoneal lymph node dissection (RPLND) and/or lung metastasectomy in cases with persistent residual mass. Following orchiectomy the patients were regularly checked and in cases with viable malignant tumor found in the testis sequential chemotherapy was administered. Similarly when the relapse of the disease was detected, the patients were treated with sequential chemotherapy. RESULTS: Complete disappearance of metastases was observed in 12 patients following chemotherapy alone. The residual mass persisted in 24 patients (in 22 out of them in the retroperitoneum and in two patients also in the lungs) and was removed surgically. The viable tumor in the removed tissue was found in one patient. Delayed orchiectomy was performed simultaneously with surgical removal of residual mass in the retroperitoneum in 24 patients and as a separate procedure in 12 patients who have been considered to be complete responders following chemotherapy alone. Residual viable tumor in testicular specimen was found in three patients, necrotic or fibrotic tissue in 18, and mature teratoma in 15 patients. Overall survival of the patients was 26/36 (72.7%) at mean of 56.9 months (range 7-145 months, median 50 months) since the start of the treatment. CONCLUSIONS: In patients with advanced germ cell testicular cancer preference must be given to the early beginning of intensive chemotherapy without the need of tissue diagnosis of primary tumor that should be obtained by orchiectomy. Benefit of this therapeutic approach is the timely management of acute abdominal and/or pulmonary symptoms of life-threatening distant metastases.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/therapeutic use , Cisplatin/therapeutic use , Germinoma/drug therapy , Orchiectomy , Testicular Neoplasms/drug therapy , Vinblastine/therapeutic use , Adult , Chemotherapy, Adjuvant , Germinoma/pathology , Germinoma/surgery , Humans , Lung Neoplasms/secondary , Male , Middle Aged , Neoplasm, Residual , Survival Rate , Teratoma/secondary , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Time Factors , Treatment Outcome
11.
Eur Urol ; 33(6): 562-6, 1998.
Article in English | MEDLINE | ID: mdl-9743698

ABSTRACT

OBJECTIVE: Surveillance after orchiectomy alone becomes popular for the management of clinical stage I nonseminomatous germ cell testicular tumours (CS I NSGCTT). Effort to identify patients at high risk of relapse leads to searching prognostic factors of CS I NSGCTT. The aim of this study was to identify those patients in whom a surveillance policy is less likely to be successful. PATIENTS AND RESULTS: Seventy-two CS I NSGCTT patients were stratified to different risk-adapted therapeutic approaches according to histopathologic findings of primary tumor removed by inguinal orchiectomy. Eighteen patients (group A) with vascular invasion and majority of embryonal carcinoma component in the primary tumor were treated with adjuvant BEP chemotherapy. None of them experienced disease progression after a median follow-up period of 36 months after orchiectomy. Five patients (group B) with vascular invasion and the majority of teratomatous elements in the primary tumor have been followed up 56 months after orchiectomy. They were treated with primary retroperitoneal lymph node dissection (RPLND). Two of them (40%) had pathologic stage II after RPLND and underwent subsequent chemotherapy. One of them died due to disease progression 29 months following orchiectomy. Another one lives with no evidence of disease (NED). Three patients in pathologic stage I are alive with NED. Forth-nine patients (group C) without vascular invasion have been followed up for a median duration of 37 months after orchiectomy. They were kept under close surveillance, consisted of regular follow-up with tumor markers, chest x-ray and CT of the retroperitoneum. Disease progression was observed in 7 (14.3%) patients after a median duration of 8 months after orchiectomy. They were treated with BEP chemotherapy and live with disease-free median survival of 22 months after completion of therapy. The overall survival rate of all 72 patients was 98.6%. The median survival for all patients was 37 months (range 7-73). CONCLUSIONS: The authors will continue to use surveillance policy only in patients without vascular invasion in the primary tumor.


Subject(s)
Germinoma/surgery , Orchiectomy , Testicular Neoplasms/surgery , Adolescent , Adult , Follow-Up Studies , Germinoma/pathology , Humans , Lymph Node Excision , Lymphatic Metastasis , Male , Neoplasm Staging , Prognosis , Retroperitoneal Space , Risk Factors , Survival Rate , Testicular Neoplasms/pathology
12.
MAGMA ; 7(3): 162-5, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10050942

ABSTRACT

Creatine kinase reaction rates were measured by magnetisation transfer technique in the brain of healthy adult and aged rats and in the rats with mild or severe chronic cerebral ischemia. These measurements indicated that the rate constant of the creatine kinase reaction is significantly reduced in the case of chronic brain ischemia in aged rats. In contrast, occlusion of both carotid arteries in adult rats produced a slight increase in the reaction rate 4 weeks after occlusion. At the same time, corresponding conventional phosphorus magnetic resonance spectra showed negligible changes in signal intensities.


Subject(s)
Brain Ischemia/enzymology , Brain/enzymology , Aging/metabolism , Animals , Chronic Disease , Kinetics , Nuclear Magnetic Resonance, Biomolecular/methods , Phosphocreatine/metabolism , Phosphorus , Rats , Rats, Wistar
13.
Vnitr Lek ; 43(9): 607-10, 1997 Sep.
Article in Slovak | MEDLINE | ID: mdl-9750471

ABSTRACT

The authors detected in a 30-year-old patient a very rare type of hyperthyroidism caused by a thyrotropin secreting pituitary adenoma. Scintigraphic examination of the pituitary by means of 111In radiolabelled octreotide revealed an increased accumulation of the radiopharmaceutical preparation in the tumour, which confirmed the high density of somatostatin receptors. After onset of octreotide treatment (Sandostatin, Sandoz, Switzerland) 3 x 100 ug/day by the s.c. route a brisk decline and normalization of thyrotropin already after the first dose was recorded. The thyroxine concentration declined slowly to the upper range of normal values. After 5 months treatment despite the positive response to receptor scintigraphy diminution of the adenoma was not recorded. Again an increase of thyrotropin above the upper limit of the reference range and a marked rise of thyroxinaemia were observed. Six months after radical selective trans-sphenoidal adenomectomy normal pituitary function was confirmed.


Subject(s)
Adenoma/drug therapy , Antineoplastic Agents, Hormonal/therapeutic use , Octreotide/therapeutic use , Pituitary Neoplasms/drug therapy , Thyrotropin/metabolism , Adenoma/diagnostic imaging , Adenoma/metabolism , Adult , Female , Humans , Pituitary Neoplasms/diagnostic imaging , Pituitary Neoplasms/metabolism , Radionuclide Imaging
14.
Bratisl Lek Listy ; 97(4): 234-6, 1996 Apr.
Article in Slovak | MEDLINE | ID: mdl-8689332

ABSTRACT

The authors analyse 34 cases of surgeries performed due to residual pulmonary metastases with germinative testicular tumours. Good results in the length of survival are ascribed to thoracotomy, or sternotomy with the resection of metastatic foci, i.e. the only method which reliably ascertains the biological nature of residual pulmonary lesion after chemotherapy. (Tab. 1, Fig. 2, Ref. 17.)


Subject(s)
Germinoma/secondary , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Testicular Neoplasms/pathology , Adolescent , Adult , Follow-Up Studies , Germinoma/mortality , Germinoma/surgery , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Survival Rate
15.
Neoplasma ; 43(3): 195-7, 1996.
Article in English | MEDLINE | ID: mdl-8841507

ABSTRACT

The prospective study, carried out from February 1992 to January 1996, included 49 patients in clinical Stage I nonseminomatous germ cell testicular tumors (NSGCTT). They were aged 16-40 years (mean, 25 years). Patients were stratified to different risk-adapted therapeutic approaches according to histopathologic findings of primary tumor removed by inguinal orchiectomy. Eleven patients of the 1st group with vascular invasion and majority of embryonal carcinoma components in the primary tumor were treated with adjuvant chemotherapy (2 cycles of BEP). None of them had disease progression after the follow-up of 4-43+ months (mean, 20.9 months) after orchiectomy. Five patients of the 2nd group with vascular invasion and majority of teratoma elements in the primary tumor were treated with primary retroperitoneal lymph node dissection (RPLND). They were followed-up 29-45+ months (mean, 33.4 months) after orchiectomy. Two of them (40%) had pathologic Stage II after RPLND and underwent subsequent BEP chemotherapy. One of them died due to disease progression in disseminated stage 29 months after orchiectomy. The second one lives with no evidence of the disease (NED). Thirty three patients in the 3rd group without vascular invasion were kept under surveillance. They were followed-up 3-48+ months (mean, 22.3 months) after orchiectomy. Disease progression was observed in 5 of them (15.1%), 7-10 months (mean, 8.8 months) following orchiectomy. These patients were treated with BEP chemotherapy and live with NED 1-16+ months (mean, 9.2 months) after completion of the therapy. The overall survival rate in clinical Stage 1 patients was 97.9%. The authors recommend the surveillance policy only in clinical Stage I NSGCTT patients without vascular invasion in the primary tumor.


Subject(s)
Germinoma/pathology , Germinoma/therapy , Testicular Neoplasms/pathology , Testicular Neoplasms/therapy , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Etoposide/administration & dosage , Follow-Up Studies , Germinoma/mortality , Humans , Male , Neoplasm Staging , Orchiectomy , Prognosis , Prospective Studies , Survival Rate , Testicular Neoplasms/mortality
16.
Neoplasma ; 43(1): 47-50, 1996.
Article in English | MEDLINE | ID: mdl-8843960

ABSTRACT

Twenty eight patients with germ cell testicular cancer pulmonary metastases received primary chemotherapy including bleomycin, etoposide, and cisplatin (BEP). Complete response was achieved in 21 (75%) patients, in 11 of them CR was achieved following chemotherapy alone. Postchemotherapy surgery of residual mass was performed in 12 (42.9%) patients with normalized serum tumor markers. Retroperitoneal lymph node dissection was performed in one patient, pulmonary surgery in four, and both postchemotherapy treatments in 7 patients. Overall cure rate was 89.3%, 26 (92.9%) patients are still alive at a mean follow-up of 19.7+ months (range, 3-34+ months) after the treatment start. Two (7.1%) patients died: one of them due to disease progression during chemotherapy, and the second one due to postoperative complication (acute respiratory failure). Relapse of disease was observed in one patient 21 months following CR achievement, and sequential chemotherapy was introduced. Authors recommend surgical remove of all radiologically detected residual deposits, because the available imaging methods are not adequate for determining the histologic composition of residual mass, which is decisive for further therapy and has prognostic value.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Germinoma/pathology , Germinoma/therapy , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Testicular Neoplasms/pathology , Testicular Neoplasms/therapy , Adolescent , Adult , Bleomycin/administration & dosage , Cisplatin/administration & dosage , Combined Modality Therapy , Etoposide/administration & dosage , Germinoma/surgery , Humans , Lung Neoplasms/surgery , Male , Orchiectomy , Testicular Neoplasms/surgery
17.
Stereotact Funct Neurosurg ; 65(1-4): 42-6, 1995.
Article in English | MEDLINE | ID: mdl-8916328

ABSTRACT

MR imaging enables the localization of the anteroposterior commissural line, but sometimes it is difficult to define the anterior commissure point. The corpus callosum is more easily identified in this case. We performed an MR imaging using the following methodology; a single transverse scan from which a coronal scan is planned with compensation. A sagittal scan is prescribed from the coronal slice, compensating for any misalignment of patient position. Finally the scan series are prescribed from the sagittal scan, following which we calculate MR distortion. This methodology was used for functional stereotaxy, and the results correlated well with the classical method.


Subject(s)
Magnetic Resonance Imaging , Neurosurgery/methods , Stereotaxic Techniques , Brain/diagnostic imaging , Brain/pathology , Humans , Spinal Cord/pathology , Tomography, X-Ray Computed
18.
Bratisl Lek Listy ; 94(5): 254-66, 1993 May.
Article in Slovak | MEDLINE | ID: mdl-8173988

ABSTRACT

The paper describes universal principles of diagnostic imaging. The attention is focused particularly on digital image generation in medicine. The methodology of display visualization of measured data is discussed. The problems of spatial relation representation and visual perception of image brightness are mentioned. The methodological issues of digital image processing (DIP) are discussed, particularly the relation of DIP to the other related disciplines, fundamental tasks in DIP and classification of DIP operations from the computational viewpoint. The following examples of applying DIP operations in diagnostic radiology are overviewed: local contrast enhancement in digital image, spatial filtering, quantitative texture analysis, synthesis of the 3D pseudospatial image based on the 2D tomogram set, multimodal processing of medical images. New trends of application of DIP methods in diagnostic radiology are outlined: evaluation of the diagnostic efficiency of DIP operations by means of ROC analysis, construction of knowledge-based systems of DIP in medicine. (Fig. 12, Ref. 26.)


Subject(s)
Diagnostic Imaging , Image Processing, Computer-Assisted , Humans , Radiography
19.
Bratisl Lek Listy ; 94(4): 201-3, 1993 Apr.
Article in Slovak | MEDLINE | ID: mdl-8353764

ABSTRACT

The contribution of the tumor marker CA 19-9 to differential diagnosis between malignant and nonmalignant diseases of the pancreas was assessed in a group of 120 patients. On using border values of CA 19-9 80 U/ml, its sensitivity was found to be 84.4% and its specificity 84.8% for carcinomas of the pancreas. Correlation of CA 19-9 values with results of computer tomography and endogenous retrograde cholangiopancreatography in the patients studied yielded an over 80% accordance. In the light of the obtained results, the authors consider determination of CA 19-9 levels to be a suitable method supplementing the imaging examination methods in suspect carcinoma of the pancreas.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/analysis , Pancreatic Neoplasms/diagnosis , Cholangiopancreatography, Endoscopic Retrograde , Chronic Disease , Diagnosis, Differential , Humans , Pancreatic Neoplasms/diagnostic imaging , Pancreatitis/diagnosis , Sensitivity and Specificity , Tomography, X-Ray Computed
20.
Neoplasma ; 40(4): 247-53, 1993.
Article in English | MEDLINE | ID: mdl-7505886

ABSTRACT

A total of 250 patients with germ cell testicular tumors were treated by PVB chemotherapy between 1982 and 1992. Mean age of patients was 28.9 years (range 15-52). Thirty-four patients in clinical Stage II (11 patients IIA, 13 patients IIB, and 10 patients IIC) underwent primary retroperitoneal lymphadenectomy (RPL) with subsequent chemotherapy. They were followed-up for a mean of 106.3 months (range 85-125). CR was achieved in 30 patients (88.2%). Three patients relapsed. Twenty-seven patients (79.4%) are alive with no evidence of disease (NED) after a minimum of 5 years since the start of therapy. One hundred and twenty-two patients underwent primary chemotherapy for clinical Stages IM (15 patients), IIA (31 patients, IIB (48 patients) and IIC (28 patients) with RPL in cases with residual mass in the retroperitoneum. They were followed-up for a mean of 47.7 months (range 6-122). CR was achieved in 115 patients (92.7%) (75 of them received chemotherapy alone, 40 patients achieved CR following combined cytostatic-surgical treatment). Eleven patients relapsed. One hundred and nine patients (89.3%) are alive with NED. Ninety-four patients in Stages III and IV (8 patients III, 86 patients IV) underwent primary chemotherapy with additional surgical removal of residual metastases. They were followed-up for a mean of 50.5 months (range 6-125). CR was achieved in 65 patients (69.1%) (32 of them received chemotherapy alone, 33 patients achieved CR following combined cytostatic-surgical treatment). Eleven patients relapsed. Fifty-seven patients (60.6%) are alive NED. There were 11 patients with advanced germ cell testicular cancer (Stages IIC and IV) who underwent initial PVB chemotherapy without previous orchiectomy. Delayed orchiectomy was done simultaneously with surgical removal of residual mass in the retroperitoneum or in the lungs or at completion of chemotherapy alone. The toxicity of chemotherapy was moderate. There were drug-related deaths in ten patients (4%).


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Germinoma/drug therapy , Teratoma/drug therapy , Testicular Neoplasms/drug therapy , Adolescent , Adult , Bleomycin/administration & dosage , Cisplatin/administration & dosage , Combined Modality Therapy , Follow-Up Studies , Germinoma/pathology , Germinoma/surgery , Humans , Lymph Node Excision , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Staging , Orchiectomy , Recurrence , Reoperation , Retrospective Studies , Teratoma/pathology , Teratoma/surgery , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Time Factors , Vinblastine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...